信號(hào)傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)多克隆抗體
Polyclonal Antibody to Signal Transducer And Activator Of Transcription 3 (STAT3)
APRF; Acute-Phase Response Factor
- 編號(hào)PAB743Mi01
- 物種Homo sapiens (Human，人), Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價(jià)-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原 RPB743Mi01-信號(hào)傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)重組蛋白
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度0.5mg/ml
- 且適物種-
- 應(yīng)用WB,IHC
如果抗體需用于流式細(xì)胞術(shù)，請(qǐng)參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價(jià)格 ¥ 616 ¥ 1436 ¥ 2052 ¥ 5130 ¥ 20520
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Figure. DAB staining on IHC-P; Samples: Human Kidney Tissue.
-
Figure. DAB staining on IHC-P;
Samples: Human Liver Tissue. -
Figure. DAB staining on IHC-P;
Samples: Human Stomach Tissue.
-
Figure. Western Blot; Sample: Recombinant STAT3, Human.
-
Western Blot; Samples: Lane1: Hela cell lysate; Lane2: NIH/3T3 cell lysate; Lane3: PC-12 cell lysate;
Primary Ab: 0.2μg/ml Rabbit Anti-Multi-species STAT3 Antibody
Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對(duì)STAT3的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別STAT3。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
抗體標(biāo)記定制服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽性對(duì)照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
長(zhǎng)臂生物素標(biāo)記試劑盒
實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人), Mus musculus (Mouse，小鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPB743Mi01 | 信號(hào)傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB743Mi02 | 信號(hào)傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB743Mi03 | 信號(hào)傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB743Mi04 | 信號(hào)傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB743Mi05 | 信號(hào)傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB743Mi03 | 信號(hào)傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB743Mi01 | 信號(hào)傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)多克隆抗體 | WB,IHC |
| PAB743Mi02 | 信號(hào)傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB743Mi04 | 信號(hào)傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB743Mi05 | 信號(hào)傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)多克隆抗體 | WB; IHC; ICC; IP. |
| MAB743Mi27 | 信號(hào)傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB743Mi22 | 信號(hào)傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB743Mi23 | 信號(hào)傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB743Mi24 | 信號(hào)傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB743Mi21 | 信號(hào)傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB743Mi25 | 信號(hào)傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)單克隆抗體 | WB; IHC; ICC; IP. |
| SEB743Mi | 信號(hào)傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB743Mi | 信號(hào)傳導(dǎo)轉(zhuǎn)錄激活因子3(STAT3)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Pharmaceutics | Oleacein and Foam Cell Formation in Human Monocyte-Derived Macrophages: A Potential Strategy Against Early and Advanced Atherosclerotic Lesions [Pubmed: 32283795] |
| CLINICAL IMMUNOLOGY | Serum ERK1/2 proteins fluctuating with HBV infection report frequency of viral-specific CD8+ T cells and predict IFNα therapeutic effect in chronic hepatitis B patients [Pubmed: 32791312] |
